An in-depth study of the CFTR gene enables selection of CFTR therapies for almost all individuals with CF
Results of a clinical evaluation of the safety and efficacy of the therapeutic drug candidate Roscovitine in people with cystic fibrosis.
Cystic fibrosis patients and health care professionals’ evaluation of a remote follow up solution with digital questionnaires and phone consultations developed due to the COVID19 pandemic.
What do we already know and what do we need to study next when looking at markers of inflammation in sputum in CF trials?
